2Liu XE, Desmyter L, Gao CF, et al. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus[J]. Hepatology, 2007; 46(5) : 1426
3Muller C. Hepatocellular carcinoma- rising incidence, changing therapeutic strategies [J]. Wien Med Wochenschr, 2006;156(13-14):404
4Poon RT. Optimal initial treatment for early hepatocellular carcinoma in patients with preserved liver function: transplantation or resection? [J]. Ann Surg Oncol, 2007; 14(2) :541
5Chen XP, Qiu FZ, Wu ZD, etal. Long-term outcome of resection of large hepatocellular carcinoma [J]. Br J Surg, 2006; 93(5) : 600
6van der Bilt JD, Kranenburg O, Verheem A, et al. Selective portal clamping to minimize hepatic ischaemia-reperfusion damage and avoid accelerated outgrowth of experimental colorectal liver metastases[J]. Br J Surg, 2006; 93(8) : 1015
7Chen XP, Qiu FZ, Wu ZD, etal. Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma[J]. Ann Surg Oncol, 2006; 13(7) : 940
8Shimada K, Sakamoto Y, Esaki M, et al. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma [J]. Ann Surg Oncol, 2007, 14(8) :2337
9Gaggioli C, Hooper S, Hidalgo-Carcedo C, etal. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells [J]. Nat Cell Biol, 2007, 9(12) : 1392
10Wang T, Niu G, Kortylewski M, et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells [J]. Nat Med, 2004,10(1) ;48
